All lobbying filings

Tiber Creek Group

Tiber Creek Group filed a Q1 report for Tiber Creek Health Strategies, Inc. (On Behalf of Novartis) on April 18, 2025, reporting $60,000 in lobbying income.

Lobbying for Tiber Creek Health Strategies, Inc. (On Behalf of Novartis) · Government relations.

As filed: TIBER CREEK GROUP for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS).

All filings by Tiber Creek Group · Everything Tiber Creek Health Strategies, Inc. (On Behalf of Novartis) has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 18, 2025

Income

$60,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation (MINI) Act.

Health Issues

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340B Drug Pricing Program; General intellectual property issues; Issues related to drug pricing; Issues related to pharmacy benefit managers.

Bills named in this filing 1

H.R. 1672
Maintaining Investments in New Innovation Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.